Investors in GSK plc Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK
Portfolio Pulse from
Law firm Levi & Korsinsky has filed a class action securities lawsuit against GSK plc, alleging the company misled investors about Zantac's safety and NDMA risks between February 2020 and August 2022. The lawsuit claims GSK knew about NDMA sources for decades before withdrawing the drug from the market, potentially causing shareholder losses.
March 26, 2025 | 11:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
The lawsuit alleges GSK misrepresented information about Zantac's safety, potentially exposing the company to significant legal and financial risks.
The lawsuit directly targets GSK's representations about Zantac, suggesting potential financial penalties, legal costs, and potential stock price impact due to investor uncertainty.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100